News for Novartis Stock (NVS)

Here's 14 Top Dividends On Earth At Ideal Prices For October

Seeking Alpha • 10/09/21

Novartis accelerates efforts toward ESG targets to increase access to medicines, improve health equity and achieve net-zero carbon emissions

GlobeNewsWire • 09/30/21

3 No-Brainer High-Yield Dividend Aristocrat Buys During This Market Slide

Seeking Alpha • 09/30/21

Novartis Posts New Data Reinforcing Efficacy, Convenience Of Cosentyx Autoinjector In Psoriasis

Benzinga • 09/29/21

This Potential Indication Could Be a Winner for Novartis

The Motley Fool • 09/29/21

7 Biotech Stocks Entering the Golden Boom Phase

InvestorPlace • 09/28/21

5 European Dividend Aristocrats Offer Huge Income and Growth Potential

24/7 Wall Street • 09/27/21

Novartis Adds Vision Loss Gene Therapy Program Via Arctos Acquisition

Benzinga • 09/21/21

Novartis buys gene therapy company Arctos Medical

Reuters • 09/21/21

Why Did Deutsche Bank Downgrade This Big Pharma Stock?

Benzinga • 09/20/21

Novartis' Kisqali Combo Therapy Extends Survival By One Year In Breast Cancer Patients

Benzinga • 09/20/21

Novartis presents new Kisqali® data showing longest median overall survival ever reported in HR+/HER2- advanced breast cancer

GlobeNewsWire • 09/19/21

Novartis announces findings from a real-world study of alpelisib demonstrating clinical benefit in people with PIK3CA-Related Overgrowth Spectrum (PROS)

GlobeNewsWire • 09/17/21

Novartis' Prostate Cancer Therapy Linked To Improved Quality Of Life

Benzinga • 09/17/21

Novartis reports positive health-related quality of life data for 177Lu-PSMA-617 radioligand therapy in patients with advanced prostate cancer at ESMO 2021

GlobeNewsWire • 09/16/21

14 High-Yield Blue Chips For A Rich Retirement

Seeking Alpha • 09/14/21

3 International Stocks to Buy for Dividend Growth

InvestorPlace • 09/08/21

Novartis Stops Iscalimab Trial In Kidney Transplant Patients

Benzinga • 09/03/21

Novartis, NHS England Ink Access Deal For Cholesterol Drug Leqvio

Benzinga • 09/01/21

Novartis to provide cholesterol-lowering drug Leqvio to 300,000 U.K. patients

Market Watch • 09/01/21

World-first agreement between Novartis and the NHS enables broad and rapid access to first-in-class cholesterol-lowering medicine Leqvio® ▼(inclisiran)

GlobeNewsWire • 08/31/21

Novartis presents important overall survival and quality-of-life results across solid tumor portfolio, among other key data at ESMO

GlobeNewsWire • 08/30/21

Novartis' STAMP Inhibitor Under FDA Review For Myeloid Leukemia

Benzinga • 08/25/21

Novartis (NVS) Kymriah Misses Primary Endpoint in NHL Study

Zacks Investment Research • 08/24/21

Novartis's Kymriah Flunks In Late-Stage NHL Study

Benzinga • 08/24/21